Mineralocorticoid secretion in essential hypertension with normal and low plasma renin activity. 1976

F H Messerli, and O Kuchel, and W Nowaczynski, and K Seth, and M Honda, and S Kubo, and R Boucher, and G Tolis, and J Genest

In 19 control subjects, 33 patients with essential hypertension and normal plasma renin activity (PRA) and 11 patients with low PRA, secretory rates of 18-hydroxy-11-deoxy-corticosterone (18-OH DOC), 11-deoxycorticosterone (DOC) and corticosterone were measured. Patients with low PRA were significantly older and had higher arterial pressure and slightly lower plasma potassium levels than patients with normal PRA. Mean 18-OH DOC secretion rate was higher in patients with normal PRA (603 +/- 112 SEM mug/24 hr) than in control subjects (219 +/- 19) and considerably higher (P less than 0.001) in patients with low PRA (1800 +/- 472). DOC and corticosterone secretion rates were within normal limits in most hypertensive patients. Plasma aldosterone was significantly higher in the hypertensive population than in control subjects whereas no significant difference was observed between the low- and normal-renin groups. A significant (P less than 0.01) mutual positive correlation was found between the secretion rates of 18-OH DOC, DOC and corticosterone in patients with low plasma renin activity. In contrast, there was no correlation between the secretion rates of the three mineralocorticoids in control subjects and patients with normal plasma renin activity. These data suggest a biosynthetic variation of the mineralocorticoid pathways in essential hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D003345 Corticosterone An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
D003900 Desoxycorticosterone A steroid metabolite that is the 11-deoxy derivative of CORTICOSTERONE and the 21-hydroxy derivative of PROGESTERONE 21-Hydroxyprogesterone,Cortexone,Deoxycorticosterone,Desoxycortone,11-Decorticosterone,21-Hydroxy-4-pregnene-3,20-dione,11 Decorticosterone,21 Hydroxy 4 pregnene 3,20 dione,21 Hydroxyprogesterone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000450 Aldosterone A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer
D015069 18-Hydroxycorticosterone 11 beta,18,21-Trihydroxypregn-4-ene-3,20-dione. 18-Hydrocorticosterone,18 Hydroxycorticosterone,18 Hydrocorticosterone,Hydroxycorticosterone, 18

Related Publications

F H Messerli, and O Kuchel, and W Nowaczynski, and K Seth, and M Honda, and S Kubo, and R Boucher, and G Tolis, and J Genest
March 1975, The Journal of clinical endocrinology and metabolism,
F H Messerli, and O Kuchel, and W Nowaczynski, and K Seth, and M Honda, and S Kubo, and R Boucher, and G Tolis, and J Genest
February 1977, The Journal of clinical endocrinology and metabolism,
F H Messerli, and O Kuchel, and W Nowaczynski, and K Seth, and M Honda, and S Kubo, and R Boucher, and G Tolis, and J Genest
December 1974, Japanese circulation journal,
F H Messerli, and O Kuchel, and W Nowaczynski, and K Seth, and M Honda, and S Kubo, and R Boucher, and G Tolis, and J Genest
May 1979, Circulation,
F H Messerli, and O Kuchel, and W Nowaczynski, and K Seth, and M Honda, and S Kubo, and R Boucher, and G Tolis, and J Genest
December 1971, Annals of internal medicine,
F H Messerli, and O Kuchel, and W Nowaczynski, and K Seth, and M Honda, and S Kubo, and R Boucher, and G Tolis, and J Genest
October 1977, The Journal of clinical endocrinology and metabolism,
F H Messerli, and O Kuchel, and W Nowaczynski, and K Seth, and M Honda, and S Kubo, and R Boucher, and G Tolis, and J Genest
January 1978, Cor et vasa,
F H Messerli, and O Kuchel, and W Nowaczynski, and K Seth, and M Honda, and S Kubo, and R Boucher, and G Tolis, and J Genest
April 1977, Polski tygodnik lekarski (Warsaw, Poland : 1960),
F H Messerli, and O Kuchel, and W Nowaczynski, and K Seth, and M Honda, and S Kubo, and R Boucher, and G Tolis, and J Genest
January 1979, Medicina,
F H Messerli, and O Kuchel, and W Nowaczynski, and K Seth, and M Honda, and S Kubo, and R Boucher, and G Tolis, and J Genest
November 1973, Nihon Jinzo Gakkai shi,
Copied contents to your clipboard!